SpaceX IPO Speculation Fuels Surge in SpaceRelated Stocks and ETFs Stellantis Turnaround Plan Prediction Market Regulation and Oura IPO Filing Lead Key Market Developments 30Year Treasury Yield Surge Pushes LongTerm Bond ETF Toward 2007 Lows Power to the People How Balcony Solar Could Help Ease Rising US Utility Costs Bond Markets Anticipate Policy Shift as Kevin Warsh Takes Helm at Fed NorthWind Estates Acquires 5Acre Land Parcel on Yamuna Expressway for Rs 189 Crore via YEIDA Auction PMTS Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Conditions AVAL Q2 2025 Earnings Strong EPS Performance Despite Market Headwinds Ames National Corporation ATLO Q1 2026 Earnings Solid EPS Beat Amid Stable Operations Stepan Company SCL Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Rises LLYVK Q4 2025 Earnings EPS Nearly Matches Estimates but Surprise Miss and Flat Revenue Weigh on Sentiment Red River Bancshares Q1 2026 Earnings EPS Surpasses Estimates Despite Modest Stock Decline Fortrea Holdings FTRE Slides Slightly Hovering Near Key Support Level Waldencast plc WALD Shows Resilience with 382 Gain Testing Key Resistance Franklin Universal Trust FT Edges Higher Approaching Key Resistance Zone Medtronic MDT Dips 12 as Shares Approach Key Support Level HCM III Acquisition Corp HCMA Edges Higher as SPAC Market Shows Mixed Signals Rising Furniture Costs Drive Shift to Resale Market Challenging LowPrice Retailers WTI Q1 2026 Earnings Earnings Miss Estimates as Losses Widen Amid Production Headwinds LANDO Preferred Shares Hover Near Support Amid Modest Trading Activity DRCT Q1 2026 Earnings Narrowing Losses as EPS Surprises to the Upside WGRX Q1 2026 Earnings Heavy Loss and Steep Selloff as Transparency Remains Limited Expion360 Q2 2025 Earnings EPS Surpasses Estimates as Narrower Loss Signals Cost Discipline AMKR Q1 2026 Earnings Strong EPS Beat Amid Mixed Signals Stock Slightly Lower SelectQuote Q1 2026 Earnings Stellar EPS Surge Driven by Operational Discipline Despite Stock Dip SCHW Q1 2026 Earnings Modest EPS Beat Amid Steady Performance Aprea Therapeutics Inc APRE Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid Clinical Progress